UNSPSC 51332102: Nemonapride

This classification denotes a dopamine antagonist and antipsychotic agent with the molecular formula C21H26ClN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q88T5P3444, chemically known as n-(2rs,3rs)-(1-benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide but generally known as nemonapride, which bears US NIH Compound Identifier 156333. European Medicines Agency schedules Nemonapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09191MIG.

UNSPSC 51332102 Nemonapride is a Commodity code that does not reflect the work actually being solicited under it in recent state and local procurement activity. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS—requests naloxone and safe drug deactivation systems for community health initiatives, a scope unrelated to nemonapride (a herbicide active ingredient). The mismatch between the code's nominal taxonomy and the actual procurement signals either a tagging error in the source database or a code that sees minimal current state and local purchasing activity.

Seminole County posted IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: the posted date and deadline appear inconsistent in the source). Quarterly deliveries were to be made to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. The contract was structured as a two-year fixed-fee award with an optional one-year renewal, subject to a three-month probationary termination period. Bidders were required to comply with E-Verify, drug-free workplace certification, and federal compliance requirements due to potential FEMA funding. Beyond this single opportunity, the code shows no recent relevant state and local procurement activity.